Adults 18 years and older seeking treatment for nasal obstruction and willing to undergo an office-based procedure.
Nasal obstruction, defined as ≥60 by the NOSE scale.
The nasal valve is the primary or significant contributor to the subject's nasal obstruction as determined by the investigator, based on clinical presentation, physical examination, or nasal endoscopy.
Subjects has symptomatic improvement with use of external or internal nasal dilators, Q-Tip or curette test (manual intranasal lateralization), or the Cottle Maneuver (manual lateral retraction of the cheek).
Subject experienced minimal symptomatic improvement after the four-week fluticasone steroid nasal spray regimen.
You may not be if
Prior surgery to the nasal valve, rhinoplasty, septoplasty, inferior turbinate reduction or other surgical nasal procedures within the past 12 months.
Severe and/or chronic sinusitis, recurrent sinusitis, or allergies leading to nasal obstruction and currently requiring oral corticosteroid therapy.
Severe case of any of the following; septal deviation, turbinate hypertrophy, polyps, or ptotic nasal tip believed to be the primary contributor to the subject's nasal obstruction symptoms and warranting surgical intervention.
Known or suspected allergies or contraindications to the anesthetic agents and/or antibiotic medications to be used during the study procedure session.
Known or suspected pregnancy, or lactation.
Other medical conditions that the investigator believed would predispose subject to poor wound healing or increased surgical risk.
Clareo Health | VivAer: A Correlation Between Symptom Scores and Objective Findings
